In node-negative breast cancer without adjuvant systemic treatment, Ki67% by DIA, but not subjective counts, is reproducible and prognostically strong. This casts serious doubt on therapeutic guidelines using subjective counts of Ki67.
No takes yet. Share an insight, caveat, or question.
Gudlaugsson et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: